Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/25/24 09:26 | 10/24/24 | LH | Health | Health | Medical Laboratories | Anderson Kerrii B | NC | D | 4 | S.m | -1,614 | 215.19 | 0 | -8 | 16 | D | ||||||||||||||||
8/21/24 09:08 | 8/19/24 | LH | Health | Health | Medical Laboratories | Van Der Vaart Sandra D | NC | O | EVP,GC | 7 | S.d | -1,850 | 218.89 | 0 | -8 | 8 | D | |||||||||||||||
8/19/24 10:22 | 8/15/24 | LH | Health | Health | Medical Laboratories | Eisenberg Glenn A | NC | O | CFO,EVP | 2 | S.d | -10,812 | 218.40 | 0 | -50 | 31 | D | |||||||||||||||
8/7/24 08:47 | 8/5/24 | LH | Health | Health | Medical Laboratories | Berberian Lance | NC | O | EVP,CIO, | 1 | S | -2,771 | 229.10 | 0 | -12 | 16 | D | |||||||||||||||
5/1/24 18:29 | 4/29/24 | LH | Health | Health | Medical Laboratories | Wilkinson Peter J | NC | O | SVP,Chie | 2 | S | -790 | 206.64 | 0 | -4 | 2 | D | |||||||||||||||
4/3/24 08:35 | 4/1/24 | LH | Health | Health | Medical Laboratories | Schroeder Mark S | NC | O | EVP,P Di | 2 | S.d | -2,510 | 217.80 | 0 | -12 | 5 | D | |||||||||||||||
4/3/24 08:34 | 4/1/24 | LH | Health | Health | Medical Laboratories | Summy Amy B. | NC | O | EVP,CMO | 2 | S | -810 | 217.36 | 0 | -4 | 4 | D | |||||||||||||||
2/22/24 15:04 | 2/21/24 | LH | Health | Health | Medical Laboratories | Divincenzo Jonathan P. | NC | O | EVP,P,Ce | 1 | S | -108 | 215.49 | 0 | -1 | 3 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |